Navigation Links
Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
Date:10/22/2007

TAXUS ATLAS studies also reinforce deliverability of TAXUS(R) Liberte(R)

drug-eluting stent in long lesions and small vessels

NATICK, Mass. and WASHINGTON, Oct. 22 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month data from the pivotal TAXUS ATLAS Small Vessel and Long Lesion studies, which evaluate the TAXUS(R) Liberte(R) Paclitaxel-Eluting Stent System in complex lesions. The TAXUS Liberte 2.25 mm Stent significantly reduced restenosis and maintained or improved safety outcomes compared to the already highly effective first- generation TAXUS Express(TM) Stent, which has been used in more than four million implants since 2003 and has been the benchmark against which many newer stents have been compared. The TAXUS Liberte Long (38 mm) Stent showed further significant reduction in the incidence of Non-Q-Wave Myocardial Infarction (MI, or heart attack) occurring at the time of the procedure compared to the earlier generation TAXUS stent. The data also demonstrated enhanced deliverability for both the TAXUS Liberte 2.25 mm Stent and for the TAXUS Liberte Long Stent.

The results were presented by Mark A. Turco, M.D., Director of the Center for Cardiac and Vascular Research, Washington Adventist Hospital, and co- principal investigator of the trial, at the Cardiovascular Research Foundation's (CRF) nineteenth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C.

"The TAXUS ATLAS studies show the TAXUS Liberte Stent to be highly deliverable in complex lesions, while significantly reducing restenosis in small vessels," said Dr. Turco. "The positive data from the TAXUS ATLAS studies suggest that improvements in
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Boston Scientific Announces Schedule for EuroPcr 2007
2. Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
3. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
4. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
5. To Stent or Not: Is That the Question?
6. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
7. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
8. Efficacy of OrbusNeichs Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
9. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
10. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
11. Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial Results at EuroPCR 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015  PAREXEL International Corporation (NASDAQ: ... and Fiscal Year 2015 on Wednesday, August 5 th , ... will be available on PAREXEL,s website at www.PAREXEL.com ... PAREXEL will host a conference call and live webcast ... 2015 to discuss the results.  To access the webcast, visit ...
(Date:7/7/2015)... , July 7, 2015   InspireMD, ... "Company"), a leader in embolic protection systems ("EPS"), ... Embolic Protection System integrated with MicroNet ™ ... Coronary Stent New Product Innovation Award.  Through active ... of analysts and consultants recognize the successful introduction ...
(Date:7/7/2015)... , July 7, 2015 EnteroMedics Inc. ... devices that use neuroblocking technology to treat obesity, metabolic ... its previously announced public offering of 32,000,000 units. Each unit ... Series A warrant to purchase one share of common ... Investors whose purchase of units in the offering would ...
Breaking Medicine Technology:PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3
... Pharma, Inc. (Amex: DDD ) today reported financial ... 30, 2009. , Stephen J. Turner, SCOLR ... discussions related to licensing our 12-hour ibuprofen formulation. Several ... and external resources as they evaluate the potential commercial ...
... international markets continued to depress sales for Allied Healthcare Products in ... , Sales declines pushed Allied into a loss for the quarter. ... negative 9 cents per share, compared to a net profit the ... , Sales fell about 21 percent in the quarter, from about ...
Cached Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6
(Date:7/7/2015)... ... July 07, 2015 , ... ... management solutions, has announced the release of Service Pack 5600 for its ... a number of enhancements to the already robust capabilities of the reporting ...
(Date:7/7/2015)... ... , ... On May 29, 2015, Health Canada announced that they had registered ... for gluten free oats and foods that contain them as ingredients. , “We are ... to include gluten-free oat products in Canada,” says Frank Massong, VP of Regulatory and ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Connexion Point is holding an onsite job fair ... held at 1769 Paragon Place, Suite 100, this upcoming Wednesday, July 8, and Thursday, July ... Connexion Point will be recruiting new applicants as well as holding onsite interviews. Interested ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... modernization, today announced they have been selected by the Department of Vermont Health ... for its Medicaid Management Information System (MMIS) and Integrated Contact Center System project. ...
(Date:7/6/2015)... ... July 06, 2015 , ... For over twenty years, ... personal injury victims. Throughout the company’s history the goal has been to be ... need in their recovery. And while Doctors on Liens has certainly achieved that ...
Breaking Medicine News(10 mins):Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:Connexion Point, a tech enabled healthcare services company, is holding on-site job fair July 8th and 9th to fill 400 positions at its new Memphis location 2Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 2Health News:Doctors on Liens Adds Transportation to Its Ever-Expanding Network 3
... May 21 /Xinhua-PRNewswire-FirstCall/ -- Benda,Pharmaceutical, Inc. (OTC Bulletin ... a commercialized gene,therapy medicine for the treatment of ... financial results for the quarter,ended March 31, 2008. ... SEC on May,20, 2008., Three Months Ended ...
... MM2 Group, Inc. (OTC,Bulletin Board: MMGP) reported on May ... Exchange Commission, net income of $2,019,862 for,the quarter ending March ... the Company. In the same time period last year, the ... months ended March 31, 2008 and 2007 were,$685,663 and $247,954, ...
... Claims Administration Helps Leading Pennsylvania ... Ala., May 21 DST Health Solutions,today announced ... Cross,a leading Pennsylvania-based health insurer serving nearly 3.4 ... Health Solutions, outsourcing center in Harrisburg, Pa. will,continue ...
... Interest in New Entity, ALLEGAN, Mich., May ... today announced that it has entered into a,collaborative ... Pentech Pharmaceuticals Inc., a privately owned company that ... dosage forms. Pentech will,contribute its ANDA filing for ...
... interventions reduce COPD hospital visits more than one-half, study ... Simple patient management can significantly reduce hospitalization and emergency ... (COPD), according to a U.S. study. , "While ... previously shown to reduce hospitalizations for COPD, until now ...
... 21 The Quantum Group,Inc. (Amex: QGP, QGP.WSA, QGP.WSB) ... successfully completed a corporate expansion plan. The Company,increased its ... facility size from 6,600 sq. ft. to 10,600 sq. ... to a larger facility in Doral (west,Miami), Florida., ...
Cached Medicine News:Health News:Benda Pharmaceutical Reports First Quarter 2008 Financial Results 2Health News:Benda Pharmaceutical Reports First Quarter 2008 Financial Results 3Health News:Benda Pharmaceutical Reports First Quarter 2008 Financial Results 4Health News:Benda Pharmaceutical Reports First Quarter 2008 Financial Results 5Health News:Benda Pharmaceutical Reports First Quarter 2008 Financial Results 6Health News:Benda Pharmaceutical Reports First Quarter 2008 Financial Results 7Health News:MM2 Group Reports Record Net Income of $2,019,862 for Quarter Ending March 31, 2008 2Health News:DST Health Solutions and Independence Blue Cross Extend Business Process Outsourcing Agreement 2Health News:DST Health Solutions and Independence Blue Cross Extend Business Process Outsourcing Agreement 3Health News:Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech 2Health News:Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech 3Health News:Perrigo Company Announces Collaborative Agreement for Generic Topical Products With Pentech 4Health News:Simple Case Management Cuts Pulmonary Disease Admissions 2Health News:The Quantum Group Completes Corporate Expansion Plan; Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 2009 2Health News:The Quantum Group Completes Corporate Expansion Plan; Employee and Corporate Office Growth Leads the Way for Enhanced Innovation and Growth Through 2009 3
This catheter is intended for ultrasound examination of coronary intravascular pathology ONLY. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
Kit for the Preparation of Technetium Tc 99m Sestamibi for injection...
Straight Tip, Measures from 0mm to 20mm in 1mm Increments, Readable on Both Sides, Thumbscrew Lock Holds Desired Setting; in Titanium....
Very fine, blunt tip....
Medicine Products: